Address: | 601 Gateway Blvd, South San Francisco, CA 94080, USA |
---|---|
Postal code: | 94080 |
Phone: | (650) 866-8070 |
Website: | https://lyricpharma.com/contact/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Lyric Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Lyric Pharmaceuticals Inc. 601 Gateway Boulevard Suite 1020 ... Phone: 650-866-8070. PRESS RELEASE. Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 ...
(650) 866-8070. Website: www.lyricpharma.com. ... Lyric Pharmaceuticals Presents Data at ASPEN Conference on the Incidence of Enteral Feeding Intolerance in the ICU.
Lyric is a clinical-stage pharmaceutical company co-founded in 2013 by David Wurtman, M.D., M.B.A., President & Chief Executive Officer and M. Scott Harris, M.D., Chief Medical Officer. "We're pleased to launch Lyric Pharmaceuticals with such a credible group of healthcare investors," said Dr. Wurtman.
Lyric Pharmaceuticals Inc. raised $26,785,593 from 13 investors on 2017-04-24. ... SUITE 1020 SOUTH SAN FRANCISCO 94080 Phone number: (650) 866-8070. Latest news.
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round. ... (650) 866-8070 info@lyricpharma.com. Media: Jennifer Cook Williams Cook Williams Communications, Inc.
About VentureDeal. Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
SOUTH SAN FRANCISCO, March 5, 2018 — Lyric Pharmaceuticals, Inc. (Lyric), a biopharmaceutical company, today announced the completion of enrollment of PROMOTE, an international, multicenter, randomized, controlled Phase 2 study of LP101 (ulimorelin) for the treatment of enteral feeding intolerance (EFI) in critically ill patients.
Lyric Pharmaceuticals Inc. Street Address 1 Street Address 2; 601 GATEWAY BLVD., SUITE 1020: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SOUTH SAN FRANCISCO: CALIFORNIA: 94080 (650) 866-8070
Email: [email protected] Phone: 650-866-8070. PRESS RELEASE. PRESS RELEASE. Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 (Ulimorelin) in Enteral Feeding Intolerance;